Myelofibrosis with myeloid metaplasia.
Tefferi
A
A
Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA. tefferi.ayalew@mayo.edu
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D003937:Diagnosis, Differential; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D013156:Splenectomy; D013498:Suramin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013498:Suramin; D006918:Hydroxyurea